Needle-Free Delivery: Technology And Market 2013-2023

April 2013 | 139 pages | ID: NA02D44AD29EN
Visiongain

Abstracts

Needle-free delivery - discover technological and commercial prospects

What does the future hold for the needle-free delivery market? Visiongain's report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for the overall needle-free injection technology market. There is urgent need for needle-free delivery methods, driven by needle/syringe safety concerns and their lack of suitability for mass immunisation programmes. Our study lets you assess sales data for the global needle-free delivery market, its submarkets and leading national markets. You also find that industry's most promising and lucrative segments, helping your research and analyses.

Forecasts and other analyses to help you stay ahead in knowledge

In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. You see qualitative analysis (SWOT analysis), business news, outlooks and developmental trends. You gain 94 tables and figures and 2 interviews with experts in the field.

Is finding commercial details a challenge? With our report you can get ahead in knowledge, benefiting your research, analyses and decisions. Discover areas that will prosper, reducing the risk of your being left behind.

You discover industry dynamics and growth potentials - the following sections show what you find in our new report.

Discover prospects for the world market and submarkets

Along with revenue prediction for the overall world market, you see forecasts to 2023 for these submarkets:

• Jet Injectors market
• Competing needle-free technology market

The competing needle-free technology market is further segmented into:

• Novel needle technology (includes microneedles and pen needles)
• Inhaler technology
• Patch technology.

With our investigation you gain business information with individual sales predictions and discussions. You find analysis of competition, as well as commercial drivers and restraints. See what's likely to achieve the most success.

You can gain competitive advantages by understanding the trends, opportunities and challenges facing the needle-free delivery market.

Our work also breaks the main world forecast into leading geographical markets.

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially the expansion of healthcare in emerging countries. There are many opportunities for companies developing needle-free technologies. See prospects for the industry.

You get individual forecasts to 2023 for nine national markets, finding overall revenues:

• US
• Japan
• Germany, France, UK, Italy and Spain
• India and China.

Discover progress and outlooks. You assess the industry's future - hear about developments and find their significance. Our work explains, exploring many issues.

What issues will affect the needle-free delivery market?

Our report discusses issues and events affecting that industry and market from 2013, looking ahead:

• Growing demand for minimally invasive delivery methods
• Mass immunisation programmes
• Booming global vaccine market
• Opportunities in the needle-free delivery market.

Also, you find coverage of these aspects:

• Regulation of needle-free delivery devices
• Needle-free devices in development
• Challenges faced by jet injectors and microneedle technology.

See what the future holds. You investigate technological, commercial, economic and political matters, with emphasis on the competitive landscape and business outlooks.

Leading companies and 2017 market value

What will happen next? We predict the overall world market for needle-free delivery devices will reach $2.4bn in 2017, and expand further to 2023.

Our study shows you what technologies, products and organisations hold greatest potential. We explore these leading companies:

• Antares Pharma
• Zogenix
• Bioject Medical Technologies
• 3M.

From 2013 to 2023, many opportunities will arise. Our work shows you the technological and commercial possibilities, helping you stay ahead.

Seven ways Needle-Free Delivery: Technology and Market 2013-2023 helps

To sum up, our investigation gives you the following knowledge:

• Revenues to 2023 for the overall world market and 5 submarkets - you discover that industry's prospects
• Forecasting to 2023 for the US, Japan, Germany, France, UK, Spain, Italy, India and China - you see leading national sales potentials
• Assessments of 4 leading companies - you find activities, products, capabilities and outlooks
• Opinions on the sector - you read our industry interviews with experts
• Understanding of competition and opportunities - you see what affects that industry, learning what shapes its future
• Analysis of what stimulates and restrains the industry and market - you assess challenges and strengths
• Prospects for established firms and those seeking to enter the sector - you explore needs, practices and outlooks for success.

Benefit from our analyses, gaining information found nowhere else

That work gives independent analysis from our primary and secondary research. You receive business intelligence found only in our study, seeing where prospects are lucrative and growth is likely.

With our report you are less likely to fall behind in knowledge or miss opportunity. See how our work could benefit your research, analyses and decisions, saving you time and getting you recognition for commercial insight.

Discover technological and commercial prospects from 2013 by ordering now

Visiongain's study is for everyone needing analysis of the industry and market for needle-free delivery technology. You find data, trends and predictions. Please ask for our report now.

Visiongain is a trading partner with the US Federal Government

Contents

1.EXECUTIVE SUMMARY

1.1 Sector Highlights
1.2 Aim, Scope and Format of This Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Relating to the Report

2. INTRODUCTION TO NEEDLE-FREE DELIVERY OF DRUG/VACCINES

2.1 What is Needle-Free Technology?
  2.1.1 History of Needle-Free Injections (NFI)
2.2 Why the Need For Needle-Free Delivery Technology?
  2.2.1 Needle Stick Injury
    2.2.1.1 Blood-Borne Pathogens and Needle Stick Injury
    2.2.1.2 Accidental Needle Stick Injury: A Serious Healthcare Problem
2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial
  2.3.1 Pain Management
  2.3.2 Vaccine Delivery
    2.3.2.1 The Global Vaccine Market, 2012-2023
    2.3.2.2 Needle-Free Vaccine Delivery
    2.3.2.3 Mass Immunisation
  2.3.3 Insulin Delivery For Diabetics
  2.3.4 Paediatric Injections
  2.3.5 Other Uses For Needle-Free Injection Technology
2.4 Advantages and Disadvantages of Needle-Free Injections
2.5 The Needle-Free Delivery Market
  2.5.1 Jet Injectors
    2.5.1.1 Strengths and Weaknesses of Jet Injectors
  2.5.2 Competing Technologies
    2.5.2.1 Novel Needle Technology
      2.5.2.1.1 Pen Needles
      2.5.2.1.2 Microneedles
      2.5.2.1.3 Hollow Microneedles
      2.5.2.1.4 Solid Coated Microneedles
      2.5.2.1.5 Solid Biodegradable Microneedles
      2.5.2.1.6 Solid Uncoated Microneedles
      2.5.2.1.7 Selection of Microneedles
    2.5.2.2 Inhaler Technology
    2.5.2.3 Patch Technology
2.6 Regulation of the Needle-Free Delivery Market
  2.6.1 The US Regulation System
  2.6.2 The European Regulation System
    2.6.2.1 Post Marketing Surveillance in the EU

3. THE NEEDLE-FREE DELIVERY TECHNOLOGY MARKET, 2013-2023

3.1 The Needle-Free Delivery Technology Market: Overview
3.2 The Needle-Free Delivery Technology Market by Segment, 2011
  3.2.1 The Needle-Free Delivery Technology Market: Breakdown by Segment, 2011
3.3 The Needle-Free Delivery Market Forecast, 2012-2023
3.4 Needle-Free Delivery Technology: Market Trends, 2013-2023
3.5 Drivers and Restraints in the Needle-Free Delivery Market, 2013-2023
  3.5.1 Drivers
    3.5.1.1 Growing Demand For Minimally Invasive Delivery Methods
    3.5.1.2 Patent Expiry Will Increase Competition
    3.5.1.3 Booming Global Vaccines Market
    3.5.1.4 Growth in Biologics Market
  3.5.2 Restraints
    3.5.2.1 Expensive Technology with Currently Limited Market Penetration
    3.5.2.2 Limited Clinical Data May Restrain the Market
    3.5.2.3 Regulatory Bodies May Restrain Market Growth

4. THE JET INJECTORS TECHNOLOGY MARKET, 2013-2023

4.1 The Jet Injectors Market: Overview
4.2 The Jet Injectors Market by Segment, 2011
4.3 The Jet Injectors Market Forecast by Leading Segments, 2012-2017
4.4 The Jet Injectors Market Forecast by Leading Segments, 2017-2023
4.5 Leading Devices in the Jet Injectors Market, 2013
  4.5.1 Biojector 2000 (Bioject Medical Technologies)
  4.5.2 SUMAVEL DosePro (Zogenix)
  4.5.3 E-Jet 100 (Eurojet Medical)
  4.5.4 STRATIS (Pharmajet)
  4.5.5 ZetaJet (Bioject Medical Technologies)
  4.5.6 LectraJet (D'Antonio Consultants International)
  4.5.7 Med-Jet (Medical International Technologies)
  4.5.8 Vision (Antares Pharma)
  4.5.9 Glide System (Glide Pharmaceutical Technologies)
  4.5.10 AdvantaJet (Activa Brand Products)
  4.5.11 J-Tip (National Medical Products)
  4.5.12 SQ-Pen (Diabetes Management International)
  4.5.13 Vitajet (Bioject Medical Technologies)
  4.5.14 Penjet (Penjet Corporation)
4.6 Jet Injectors Development Pipeline, 2013
  4.6.1 Zeneo (Crossject Medical Technologies)
  4.6.2 Jupiter Jet (Bioject Medical Technologies)
  4.6.3 Iject (Bioject Medical Technologies)
  4.6.4 Iject R (Bioject Medical Technologies)
  4.6.5 Relday (Zogenix)
4.7 Concluding Remarks

5. COMPETING NEEDLE-FREE TECHNOLOGY MARKET, 2013-2023

5.1 Competing Needle-Free Technologies: Overview
5.2 Competing Needle-Free Technology Market, 2011
5.3 Competing Needle-Free Technologies Market Forecast by Leading Segments, 2012-2017
5.4 Competing Needle-Free Technologies Market Forecast by Leading Segments, 2017-2023
5.5 Novel Needle Technology, 2011
  5.5.1 Novel Needle Technology Market Forecast, 2012-2023
  5.5.2 Leading Products in the Microneedle Technology Market, 2013
5.6 Inhaler Technology Market, 2011
  5.6.1 Inhaler Technology Market Forecast, 2012-2023
  5.6.2 Inhalers in the Asthma Market, 2013
  5.6.3 Inhalers in the Insulin Market, 2013
  5.6.4 Inhalers in the Vaccine Market, 2013
5.7 Patch Technology Market, 2011
  5.7.1 Patch Technology Market Forecast, 2012-2023
  5.7.2 Drug Patches in the Market, 2013
  5.7.3 Patches For Vaccine Delivery, 2013
5.8 Competing Needle-Free Technology Development Pipeline, 2013
  5.8.1 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore)
  5.8.2 Microneedle Patch For the Polio Vaccine (Georgia Tech's School of Chemical and Biomolecular Engineering)
  5.8.3 AdminPen (nanoBioSciences)
  5.8.4 PKA SoftTouch (PKA SoftTouch Corp)
  5.8.5 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)
  5.8.6 Inhalable Measles Vaccine (Johns Hopkins Bloomberg School of Public Health and the University of Colorado)
  5.8.7 Nanotechnology Implant (University of California, San Francisco)
  5.8.8 DrugMAT (TheraJect)
  5.8.9 MicroCor (Corium International)
5.9 Concluding Remarks

6. LEADING NATIONAL NEEDLE-FREE DELIVERY MARKETS, 2013-2023

6.1 Regional Breakdown of the Needle-Free Delivery Market, 2011
6.2 Needle-Free Delivery Market: Regional Forecast, 2012-2023
6.3 The US Market
6.4 The European Market
  6.4.1 The German Market
  6.4.2 The French Market
  6.4.3 The Italian Market
  6.4.4 The Spanish Market
  6.4.5 The UK Market
6.5 The Japanese Market
6.6 The Chinese Market
6.7 The Indian Market

7. LEADING COMPANIES IN THE NEEDLE-FREE DELIVERY MARKET

7.1 Antares Pharma
  7.1.1 Sales and Performance Analysis, 2012
  7.1.2 Product Sales, 2012
  7.1.3 Technology of Antares Pharma
    7.1.3.1 Pressure Assisted Injection Devices
    7.1.3.2 Transdermal Gel System
  7.1.4 Marketed Products, 2013
  7.1.5 Pipeline Products, 2013
7.2 Zogenix
  7.2.1 Sales and Performance Analysis, 2011
  7.2.2 DosePro - Core Technology of Zogenix
  7.2.3 Marketed Products, 2013
  7.2.4 Pipeline Products, 2013
7.3 Bioject Medical Technologies
  7.3.1 Sales and Performance Analysis
  7.3.2 Core Technology of Bioject
  7.3.3 Marketed Products, 2013
7.4 3M
  7.4.1 Sales and Performance Analysis, 2011
  7.4.2 3M Drug Delivery Systems

8. QUALITATIVE ANALYSIS OF THE NEEDLE-FREE DELIVERY MARKET, 2013-2023

8.1 SWOT Analysis of the Needle-Free Delivery Market, 2013-2023
8.2 Strengths
  8.2.1 Needle-Free Injections Offer a Less Painful Alternative
  8.2.2 No Specialist Training Required For Drug/Vaccine Delivery
  8.2.3 Reduction in Transport Costs
8.3 Weaknesses
  8.3.1 Current Technology is Very Expensive
  8.3.2 The Manufacturing Process is Slow and Inefficient
  8.3.3 Many Drugs Need Reformulating Before Use with Needle-Free Injection Technology
8.4 Opportunities
  8.4.1 Emerging Economies Offer Significant Growth Opportunities
  8.4.2 Mass Immunisation Programmes Across the Globe
  8.4.3 DNA and Other Vaccines Offer Opportunity For Growth
8.5 Threats
  8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce
  8.5.2 Limited Clinical Data Threatens to Stifle Innovation and Restrain the Market
  8.5.3 Medical Device Excise Tax

9. EXPERT OPINIONS

9.1 Interview with John Turanin, Vice President and General Manager, Zogenix
  9.1.1 The Needle-Free Injection Technology Market
  9.1.2 Impact of Needle-Free Jet Injectors on Drug and Vaccine Delivery
  9.1.3 On SUMAVEL DosePro, a Leading Product in the Market
  9.1.4 Factors Limiting the Growth of Jet Injectors
9.2 Interview with Dr Faz Chowdhury, Chief Executive Officer of Nemaura Pharma
  9.2.1 Challenges Limiting the Growth of Transdermal Delivery
  9.2.2 Growth of Microneedle Patch Technology
  9.2.3 Thoughts on Other Needle-Free Technologies in the Market

10. CONCLUSIONS

10.1 The Needle-Free Delivery Market, 2013-2023
10.2 Gas/Air Powered Jet Injectors Will Drive the Jet Injectors Market
10.3 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market
10.4 Concluding Remarks

List Of Tables

LIST OF TABLES

Table 2.1 The Global Vaccine Market Forecast ($bn), 2011-2023
Table 2.2 Rationale For Needle-Free Vaccine Delivery
Table 2.3 Key Examples of Needle-Free Vaccine Delivery Systems, 2013
Table 2.4 Key Examples of Needle-Free Insulin Delivery Systems For Diabetics, 2013
Table 2.5 Advantages and Disadvantages of Needle-Free Injections
Table 2.6 Classification of Jet Injectors by Method of Propulsion
Table 2.7 Strengths and Weaknesses of Jet Injectors
Table 2.8 Pen Needle Technology by Needle Length
Table 2.9 FDA Guidance on Regulation of Needle-Free Injectors, 2013
Table 3.1 The Needle-Free Delivery Market: Sales ($m) and Market Shares (%) by Segment, 2011
Table 3.2 The Needle-Free Delivery Market Forecast ($m) by Segment, 2011-2023
Table 3.3 Drivers and Restraints in the Needle-Free Delivery Market, 2013-2023
Table 3.4 Patent Expiries For Leading Drugs, 2011-2013
Table 3.5 The Global Vaccine Market Forecast ($bn), 2011-2023
Table 4.1 The Jet Injectors Market: Sales ($m) and Market Shares (%) by Segment, 2011
Table 4.2 The Jet Injectors Market Forecast ($m), 2011-2017
Table 4.3 The Jet Injector Market Forecast ($m), 2017-2023
Table 4.4 Leading Devices in the Jet Injectors Market, 2013
Table 4.5 The Jet Injectors Development Pipeline, 2013
Table 4.6 Crossject: Zeneo Development Pipeline, 2013
Table 5.1 Competing Needle-Free Technology Market: Sales ($m) and Market Shares (%) by Segment, 2011
Table 5.2 Competing Needle-Free Technology Market Forecast ($m) by Segment, 2011-2017
Table 5.3 Competing Needle-Free Technology Market Forecast ($m) by Segment, 2017-2023
Table 5.4 Novel Needle Technology Market Forecast ($m), 2011-2023
Table 5.5 Leading products in the Novel Needle Technology Market, 2013
Table 5.6 Inhaler Technology Market Forecast ($m), 2011-2023
Table 5.7 Leading Inhalers in the Asthma Market, 2013
Table 5.8 Insulin Inhalers Previously Developed and Availability in 2013
Table 5.9 Vaccine Inhalers Currently Under Development, 2013
Table 5.10 Patch Technology Market Forecast ($m), 2011-2023
Table 5.11 Drug Patches in the Market, 2013
Table 5.12 Competing Needle-Free Technology Development Pipeline, 2013
Table 6.1 Leading National Needle-Free Delivery Markets: Sales ($m) and Market Shares (%), 2011
Table 6.2 Needle-Free Delivery Market Forecast ($m) by Leading National Markets, 2011-2017
Table 6.3 Needle-Free Delivery Market Forecast ($m) by Leading National Markets, 2017-2023
Table 6.4 The Leading European Needle-Free Delivery National Markets: Sales ($m) and Market Shares (%), 2011
Table 6.5 The European Needle-Free Delivery Market Forecast ($m) by Leading Countries, 2011-2017
Table 6.6 The European Needle-Free Delivery Market Forecast ($m) by Leading Countries, 2017-2023
Table 7.1 Antares Pharma: Revenue ($m) and Revenue Shares (%) by Business, 2012
Table 7.2 Antares Pharma: Revenue ($m) and Revenue Shares (%), by Product Type, 2012
Table 7.3 Antares Pharma: Products Under Development, 2013
Table 7.4 Zogenix: Revenue ($m) and Revenue Shares (%), by Business, 2011
Table 7.5 Bioject: Revenue ($m) and Revenue Shares (%), by Product Line, 2011
Table 7.6 3M: Net Sales ($bn) and Net Sales Shares (%) by Business Segments, 2011
Table 8.1 SWOT Analysis of the Needle-Free Delivery Market, 2013-2023
Table 8.2 Average Price For Needle-Free Drug/Vaccine Delivery Technology, 2013
Table 10.1 Leading Segments of the Needle-Free Delivery Market ($m), 2011, 2013, 2017 & 2023

About

The Jet Injectors Market: Overview

In this chapter we discuss the jet injectors market, including analyses of three key segments of this market: gas/air powered jet injectors, spring powered jet injectors and battery powered injectors. This chapter contains our forecasts for growth, based on our analyses of the current and pipeline products.

The Jet Injectors Market by Segment, 2011

The total jet injectors market was valued at $570.0m in 2011, according to visiongain estimates. This represents a 52.3% share of the total needle-free delivery devices market in 2011. The gas/air powered jet injectors market was the largest segment of the jet injectors market with sales worth $395.0m, representing a 69.3% share of the total jet injectors market (Table 4.1 and Figures 4.1-4.2). The spring powered injectors market generated sales worth $120.8m; accounting for a market share of 21.2%. The smallest segment of the Jet injector market was the battery powered devices segment. In 2011, the battery powered devices market was valued at $54.2m; this represents a 9.5% share of the total jet injectors market.